Drug
macrogol3350 NA sulphate NACL KCL ascorbic acid NA ascorbate
macrogol3350 NA sulphate NACL KCL ascorbic acid NA ascorbate is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
2
50%
Ph phase_3
2
50%
Phase Distribution
0
Early Stage
2
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
2(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 22 (50.0%)
Phase 32 (50.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_3
MOVIPREP® Versus NaP Pivotal Phase III Study
NCT00322062
completedphase_3
A Phase III Trial to Assess the Efficacy, Acceptability and Safety of Moviprep® Versus a 4L PEG+E Standard Solution
NCT00389233
completedphase_2
Clinical Evaluation of a New Reduced Volume Bowel Preparation
NCT00321230
completedphase_2
MOVIPREP® Versus PICOLAX® Pilot Study
NCT00312481
Clinical Trials (4)
Showing 4 of 4 trials
NCT00322062Phase 3
MOVIPREP® Versus NaP Pivotal Phase III Study
NCT00389233Phase 3
A Phase III Trial to Assess the Efficacy, Acceptability and Safety of Moviprep® Versus a 4L PEG+E Standard Solution
NCT00321230Phase 2
Clinical Evaluation of a New Reduced Volume Bowel Preparation
NCT00312481Phase 2
MOVIPREP® Versus PICOLAX® Pilot Study
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4